Home › Myelofibrosis › North Carolina › Durham
Pag-aaral pangklinika para sa Myelofibrosis sa Durham, NC
Isang pag-aaral para sa Myelofibrosis ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Durham. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
Nagre-recruitPhase 1/2
- Duke Cancer Institute, Durham
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
Nagre-recruitPhase 3
- Duke Blood Cancer Center, Durham
A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
Nagre-recruitPhase 1
- University of North Carolina At Chapel Hill, Chapel Hill · 10 mi ang layo
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Nagre-recruitPhase 1
- Duke University Medical Center, Department of Hematologic Malignancies and Cellular Therapy, Durham
- University of North Carolina At Chapel Hill, Chapel Hill · 10 mi ang layo
Registry of Older Patients With Cancer
Nagre-recruitObservasyonal na pag-aaral
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi ang layo
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
Nagre-recruitPhase 1
- University of North Carolina, Chapel Hill · 10 mi ang layo
A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
Nagre-recruitPhase 3
- DUHS Duke Blood Cancer Center ( Site 6005), Durham
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Nagre-recruitPhase 2
- University of North Carolina, Chapel Hill · 10 mi ang layo
A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
Nagre-recruitPhase 2
- Duke University, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 mi ang layo
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Nagre-recruitObservasyonal na pag-aaral
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi ang layo
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Nagre-recruitPhase 3
- Duke University Medical Center, Durham
Pag-aaral para sa Myelofibrosis sa ibang lungsod
- Houston, TX19 pag-aaral
- New York City, NY18 pag-aaral
- Boston, MA12 pag-aaral
- Seattle, WA11 pag-aaral
- Columbus, OH11 pag-aaral
- Salt Lake City, UT10 pag-aaral
- Miami, FL10 pag-aaral
- Nashville, TN9 pag-aaral
- Baldwin Park, CA9 pag-aaral
- Atlanta, GA9 pag-aaral
- Tampa, FL9 pag-aaral
- Cleveland, OH9 pag-aaral
Iba pang pag-aaral sa Durham
- Kanser sa Suso64 pag-aaral
- Kanser (lahat ng uri)58 pag-aaral
- Non-Small Cell Lung Cancer39 pag-aaral
- Multiple Myeloma37 pag-aaral
- Acute Myeloid Leukemia33 pag-aaral
- Metastatic Cancer33 pag-aaral
- Kanser sa Prostate32 pag-aaral
- Kanser sa Baga32 pag-aaral
- Colorectal Cancer28 pag-aaral
- Kanser sa Ovary27 pag-aaral
- Chronic Lymphocytic Leukemia27 pag-aaral
- Pagkabigo ng Puso26 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.